SORAFENIB Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sorafenib, and what generic alternatives are available?
Sorafenib is a drug marketed by Apotex, Dr Reddys, Mylan, Teva Pharms Usa Inc, Torrent, and Yabao Pharm. and is included in six NDAs.
The generic ingredient in SORAFENIB is sorafenib tosylate. There are thirteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the sorafenib tosylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sorafenib
A generic version of SORAFENIB was approved as sorafenib tosylate by MYLAN on September 10th, 2020.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SORAFENIB?
- What are the global sales for SORAFENIB?
- What is Average Wholesale Price for SORAFENIB?
Summary for SORAFENIB
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| Drug Prices: | Drug price information for SORAFENIB |
| DailyMed Link: | SORAFENIB at DailyMed |
US Patents and Regulatory Information for SORAFENIB
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex | SORAFENIB TOSYLATE | sorafenib tosylate | TABLET;ORAL | 212228-001 | Jan 27, 2025 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva Pharms Usa Inc | SORAFENIB TOSYLATE | sorafenib tosylate | TABLET;ORAL | 209567-001 | Nov 12, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Dr Reddys | SORAFENIB TOSYLATE | sorafenib tosylate | TABLET;ORAL | 216073-001 | Jun 7, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Mylan | SORAFENIB TOSYLATE | sorafenib tosylate | TABLET;ORAL | 207012-001 | Sep 10, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Yabao Pharm | SORAFENIB TOSYLATE | sorafenib tosylate | TABLET;ORAL | 209050-001 | Nov 9, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
